Grantham, Mayo, Van Otterloo & Co. LLC
Source: SEC Form 13F · as of Mar 2026Grantham, Mayo, Van Otterloo & Co. LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $304.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$304.9M
BioSniper AIPage context preserved
Prepared research question
What matters most for GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,522,566 | $194.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 55,353 | $42.8M |
| INCYIncyte Corp. | 364,657 | $34.3M |
| FOLDAMICUS THERAPEUTICS, INC. | 941,266 | $13.6M |
| SNYSanofi | 189,071 | $9.1M |
| GILDGILEAD SCIENCES, INC. | 35,836 | $5.0M |
| OGNOrganon & Co. | 448,874 | $2.7M |
| EXELEXELIXIS, INC. | 38,235 | $1.6M |
| RDYDR REDDYS LABORATORIES LTD | 28,441 | $394K |
| ALTAltimmune, Inc. | 126,389 | $389K |
| HRMYHarmony Biosciences Holdings, Inc. | 11,182 | $313K |
| RNAAtrium Therapeutics Inc. | 15,444 | $206K |
| LRMRLarimar Therapeutics, Inc. | 13,065 | $59K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.